BCM
Bayesian Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-21,100
| Closed | -$1.9M | – | 1010 |
|
|
2024
Q4 | $1.9M | Buy |
+21,100
| New | +$1.9M | 0.23% | 130 |
|
|
2024
Q3 | – | Sell |
-17,100
| Closed | -$1.59M | – | 1080 |
|
|
2024
Q2 | $1.59M | Buy |
17,100
+9,523
| +126% | +$883K | 0.18% | 151 |
|
|
2024
Q1 | $719K | Sell |
7,577
-496
| -6% | -$47.1K | 0.07% | 364 |
|
|
2023
Q4 | $721K | Sell |
8,073
-18,585
| -70% | -$1.66M | 0.08% | 301 |
|
|
2023
Q3 | $1.95M | Buy |
+26,658
| New | +$1.95M | 0.22% | 116 |
|
|
2023
Q1 | – | Sell |
-11,703
| Closed | -$971K | – | 1131 |
|
|
2022
Q4 | $971K | Sell |
11,703
-14,697
| -56% | -$1.22M | 0.14% | 184 |
|
|
2022
Q3 | $2.09M | Sell |
26,400
-3,542
| -12% | -$281K | 0.42% | 44 |
|
|
2022
Q2 | $2.22M | Buy |
+29,942
| New | +$2.22M | 0.41% | 34 |
|
|
2022
Q1 | – | Sell |
-16,900
| Closed | -$1.89M | – | 944 |
|
|
2021
Q4 | $1.89M | Buy |
+16,900
| New | +$1.89M | 0.6% | 35 |
|
|
2021
Q3 | – | Sell |
-7,400
| Closed | -$1M | – | 574 |
|
|
2021
Q2 | $1M | Buy |
+7,400
| New | +$1M | 0.26% | 100 |
|
|
2020
Q4 | – | Sell |
-7,400
| Closed | -$825K | – | 689 |
|
|
2020
Q3 | $825K | Buy |
+7,400
| New | +$825K | 0.2% | 133 |
|
|
2020
Q2 | – | Sell |
-4,548
| Closed | -$352K | – | 823 |
|
|
2020
Q1 | $352K | Sell |
4,548
-2,552
| -36% | -$198K | 0.08% | 401 |
|
|
2019
Q4 | $675K | Sell |
7,100
-7,200
| -50% | -$685K | 0.12% | 237 |
|
|
2019
Q3 | $1.09M | Buy |
+14,300
| New | +$1.09M | 0.21% | 126 |
|
|
2019
Q1 | – | Sell |
-6,900
| Closed | -$495K | – | 789 |
|
|
2018
Q4 | $495K | Buy |
+6,900
| New | +$495K | 0.1% | 287 |
|
|
2016
Q4 | – | Sell |
-3,200
| Closed | -$212K | – | 722 |
|
|
2016
Q3 | $212K | Buy |
+3,200
| New | +$212K | 0.14% | 272 |
|